The Indian authorities have ordered an immediate withdrawal of rabies vaccines from the market and have also banned its imports from a Chinese manufacturer that allegedly fabricated records, a government official said today.
The Drug Controller General of India is likely to issue a show cause notice to the company, which imports the vaccine, seeking an explanation for supplying sub-standard medicine, the official said.
"We have ordered an immediate withdrawal of rabies vaccines for the time being till the investigation in the matter is completed," he said.
"As per law, the importer should have informed us if there was any problem with the overseas supplier but he did not inform us," the official said.
According to the National Rabies Control Programme, Rabies kills an estimated 20,000 people in the country each year. Rabies is spread when an infected animal scratches or bites another animal or human. Globally, the disease is most commonly caused by dog bites.
The officials at the Central Drugs Standard Control Organization (CDSCO) are compiling a detailed report on the import and distribution of the vaccine.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
